Nasal Cannula Market Report 2025

This Nasal Cannula market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The nasal cannula market size has grown strongly in recent years. It will grow from $8.93 billion in 2024 to $9.82 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period can be attributed to factors such as the rise in personalized patient care, the increasing prevalence of obstructive sleep apnea, greater awareness of respiratory diseases, lifestyle changes, and a growing population.

The nasal cannula market size is expected to see strong growth in the next few years. It will grow to $14.17 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth during the forecast period can be attributed to factors such as the rising prevalence of respiratory diseases, increased healthcare spending, a growing geriatric population, expanding government initiatives, and a higher number of surgeries. Key trends expected to shape the forecast period include technological advancements, strategic collaborations, facility expansions, increased investment in research and development, and a focus on product launches.

The growing prevalence of respiratory diseases is a key factor driving the expansion of the nasal cannula market. These diseases, which affect the lungs and airways, hinder proper breathing and oxygen exchange. The rise in respiratory conditions is primarily due to factors such as air pollution, smoking, viral infections, and heightened exposure to allergens. Nasal cannulas are commonly used to provide supplemental oxygen directly into the nostrils, helping to improve oxygen levels for patients with breathing difficulties. For example, in June 2024, the American Lung Association, a US-based non-profit organization, reported that in 2022, approximately 44.2 million Americans, or 13.5% of the population, had been diagnosed with asthma by a healthcare professional. As a result, the increasing number of respiratory diseases contributes to the growth of the nasal cannula market.

Leading companies in the nasal cannula market are concentrating on technological advancements, such as low-flow nasal cannulas, to improve patient comfort, enhance oxygen delivery efficiency, and fulfill specific clinical needs. A low-flow nasal cannula is a device that administers supplemental oxygen at lower flow rates, typically between 1 and 6 liters per minute, through two prongs placed in the nostrils. For example, in May 2024, CNSAC MedShop, a diagnostics and consumables company based in Germany, launched NasalOxy, an innovative, patented low-flow nasal cannula aimed at overcoming the limitations of conventional oxygen delivery methods. This cutting-edge device ensures exceptional comfort and effectiveness for patients requiring long-term oxygen therapy while providing flexibility for supporting both nasal and oral breathing. The design of NasalOxy minimizes contact with the mucous membranes, reducing irritation and discomfort, and eliminates common side effects typically associated with traditional nasal cannulas.

In January 2022, ICU Medical Inc., a US-based manufacturer of medical devices and systems, purchased Smiths Medical from Smiths Group plc for $2.5 billion. This acquisition is anticipated to boost ICU Medical’s market position, expand its product portfolio, and improve operational efficiencies, paving the way for sustained growth and innovation in the healthcare industry. Smiths Medical Inc., a US-based company, specializes in the provision of nasal cannulas.

Major players in the nasal cannula market are Cardinal Health Inc., Medline Industries Inc., Becton Dickinson and Company, ResMed Inc., Teleflex Incorporated, Angiplast Pvt. Ltd., Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC, Well Lead Medical Co. Ltd., GaleMed Corp., Vapotherm Inc., Salter Labs Inc., Dynarex Corporation, Mais India Medical Devices Pvt. Ltd., Allied Medical LLC, Besmed Health Business Corp., Flexicare Medical Ltd., Medin Medical Innovations AB, Airways Surgical Pvt. Ltd., Great Group Medical Co. Ltd., and HUM GmbH.

North America was the largest region in the nasal cannula market in 2024. The regions covered in nasal cannula report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the nasal cannula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A nasal cannula is a medical device designed to provide supplemental oxygen to patients in need of respiratory assistance. It features two small prongs that fit into the nostrils, connected by a thin tube to an oxygen source. This device delivers a continuous flow of oxygen, allowing the patient to breathe comfortably while still being able to speak and eat.

Nasal cannulas are primarily available in two types, low-flow and high-flow. A low-flow nasal cannula is a device that delivers a modest amount of oxygen through prongs placed in the nostrils to assist patients with breathing difficulties. Constructed from materials such as plastic and silicone, it comes in various sizes, such as neonate, infant, child, and adult, and is available in multiple prong designs, including straight, curved, flared, and others. It is used in diverse healthcare settings, including hospitals, ambulatory healthcare services, long-term care centers, and other medical environments.

The nasal cannula market research report is one of a series of new reports that provides nasal cannula market statistics, including the nasal cannula industry global market size, regional shares, competitors with the nasal cannula market share, detailed nasal cannula market segments, market trends, and opportunities, and any further data you may need to thrive in the nasal cannula industry. This nasal cannula market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nasal cannula market consists of sales of standard nasal cannulas, pediatric nasal cannulas, disposable nasal cannulas, and reusable nasal cannulas. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.